Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Pravastatin Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 10mg tablet
  • 1.3.3 20mg tablet
  • 1.3.4 40mg tablet
  • 1.3.5 80mg tablet
• 1.4 Market Segment by Application
  • 1.4.1 Global Pravastatin Market Share by Application (2019-2025)
  • 1.4.2 Adults
  • 1.4.3 Children
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Pravastatin Market Size
  • 2.1.1 Global Pravastatin Revenue 2014-2025
  • 2.1.2 Global Pravastatin Sales 2014-2025
• 2.2 Pravastatin Growth Rate by Regions
  • 2.2.1 Global Pravastatin Sales by Regions 2014-2019
  • 2.2.2 Global Pravastatin Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Pravastatin Sales by Manufacturers
  • 3.1.1 Pravastatin Sales by Manufacturers 2014-2019
  • 3.1.2 Pravastatin Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Pravastatin Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pravastatin Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Pravastatin Market Concentration Ratio (CR5 and HHI)
• 3.3 Pravastatin Price by Manufacturers
• 3.4 Key Manufacturers Pravastatin Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Pravastatin Market
• 3.6 Key Manufacturers Pravastatin Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 10mg tablet Sales and Revenue (2014-2019)
  • 4.1.2 20mg tablet Sales and Revenue (2014-2019)
  • 4.1.3 40mg tablet Sales and Revenue (2014-2019)
  • 4.1.4 80mg tablet Sales and Revenue (2014-2019)
• 4.2 Global Pravastatin Sales Market Share by Type
• 4.3 Global Pravastatin Revenue Market Share by Type
• 4.4 Pravastatin Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Pravastatin Sales by Application

6 United States

• 6.1 United States Pravastatin Breakdown Data by Company
• 6.2 United States Pravastatin Breakdown Data by Type
• 6.3 United States Pravastatin Breakdown Data by Application

7 European Union

• 7.1 European Union Pravastatin Breakdown Data by Company
• 7.2 European Union Pravastatin Breakdown Data by Type
• 7.3 European Union Pravastatin Breakdown Data by Application

8 China

• 8.1 China Pravastatin Breakdown Data by Company
• 8.2 China Pravastatin Breakdown Data by Type
• 8.3 China Pravastatin Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Pravastatin Breakdown Data by Company
• 9.2 Rest of World Pravastatin Breakdown Data by Type
• 9.3 Rest of World Pravastatin Breakdown Data by Application
• 9.4 Rest of World Pravastatin Breakdown Data by Countries
  • 9.4.1 Rest of World Pravastatin Sales by Countries
  • 9.4.2 Rest of World Pravastatin Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Bristol-Myers Squibb
  • 10.1.1 Bristol-Myers Squibb Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Pravastatin
  • 10.1.4 Pravastatin Product Introduction
  • 10.1.5 Bristol-Myers Squibb Recent Development
• 10.2 TEVA
  • 10.2.1 TEVA Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Pravastatin
  • 10.2.4 Pravastatin Product Introduction
  • 10.2.5 TEVA Recent Development
• 10.3 SANDOZ
  • 10.3.1 SANDOZ Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Pravastatin
  • 10.3.4 Pravastatin Product Introduction
  • 10.3.5 SANDOZ Recent Development
• 10.4 APOTEX
  • 10.4.1 APOTEX Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Pravastatin
  • 10.4.4 Pravastatin Product Introduction
  • 10.4.5 APOTEX Recent Development
• 10.5 Dr. Reddy's Laboratories
  • 10.5.1 Dr. Reddy's Laboratories Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Pravastatin
  • 10.5.4 Pravastatin Product Introduction
  • 10.5.5 Dr. Reddy's Laboratories Recent Development
• 10.6 Zydus Pharmaceuticals
  • 10.6.1 Zydus Pharmaceuticals Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Pravastatin
  • 10.6.4 Pravastatin Product Introduction
  • 10.6.5 Zydus Pharmaceuticals Recent Development
• 10.7 Cipla Inc.
  • 10.7.1 Cipla Inc. Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Pravastatin
  • 10.7.4 Pravastatin Product Introduction
  • 10.7.5 Cipla Inc. Recent Development
• 10.8 Lupin Pharmaceuticals
  • 10.8.1 Lupin Pharmaceuticals Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Pravastatin
  • 10.8.4 Pravastatin Product Introduction
  • 10.8.5 Lupin Pharmaceuticals Recent Development
• 10.9 Glenmark
  • 10.9.1 Glenmark Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Pravastatin
  • 10.9.4 Pravastatin Product Introduction
  • 10.9.5 Glenmark Recent Development
• 10.10 Mylan
  • 10.10.1 Mylan Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Pravastatin
  • 10.10.4 Pravastatin Product Introduction
  • 10.10.5 Mylan Recent Development
• 10.11 Aurobindo Pharma
• 10.12 Accord Healthcare
• 10.13 Upsher-Smith Laboratories
• 10.14 Hisun
• 10.15 Jiangxi Boyaseehot Pharmaceutical
• 10.16 Shanghai Shyndec Pharmaceutical
• 10.17 Daiichi Sankyo
• 10.18 North China Pharmaceutical Group

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Pravastatin Sales Channels
  • 11.2.2 Pravastatin Distributors
• 11.3 Pravastatin Customers

12 Market Forecast

• 12.1 Global Pravastatin Sales and Revenue Forecast 2019-2025
• 12.2 Global Pravastatin Sales Forecast by Type
• 12.3 Global Pravastatin Sales Forecast by Application
• 12.4 Pravastatin Forecast by Regions
  • 12.4.1 Global Pravastatin Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Pravastatin Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Pravastatin (marketed as Pravachol or Selektine) is a member of the drug class of statins, used in combination with diet, exercise, and weight loss for lowering cholesterol and preventing cardiovascular disease.
In 2019, the market size of Pravastatin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pravastatin.

This report studies the global market size of Pravastatin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pravastatin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Bristol-Myers Squibb
TEVA
SANDOZ
APOTEX
Dr. Reddy's Laboratories
Zydus Pharmaceuticals
Cipla Inc.
Lupin Pharmaceuticals
Glenmark
Mylan
Aurobindo Pharma
Accord Healthcare
Upsher-Smith Laboratories
Hisun
Jiangxi Boyaseehot Pharmaceutical
Shanghai Shyndec Pharmaceutical
Daiichi Sankyo
North China Pharmaceutical Group

Market Segment by Product Type
10mg tablet
20mg tablet
40mg tablet
80mg tablet

Market Segment by Application
Adults
Children

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Pravastatin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pravastatin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Pravastatin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025